These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32719097)

  • 1. A novel method to interpret early phase trials shows how the narrowing of the coronary sinus concordantly improves symptoms, functional status and quality of life in refractory angina.
    Jolicoeur EM; Verheye S; Henry TD; Joseph L; Doucet S; White CJ; Edelman E; Banai S
    Heart; 2021 Jan; 107(1):41-46. PubMed ID: 32719097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial.
    Jolicœur EM; Banai S; Henry TD; Schwartz M; Doucet S; White CJ; Edelman E; Verheye S
    Trials; 2013 Feb; 14():46. PubMed ID: 23413981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a device to narrow the coronary sinus in refractory angina.
    Verheye S; Jolicœur EM; Behan MW; Pettersson T; Sainsbury P; Hill J; Vrolix M; Agostoni P; Engstrom T; Labinaz M; de Silva R; Schwartz M; Meyten N; Uren NG; Doucet S; Tanguay JF; Lindsay S; Henry TD; White CJ; Edelman ER; Banai S
    N Engl J Med; 2015 Feb; 372(6):519-27. PubMed ID: 25651246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina: A Single-Center Experience.
    Giannini F; Baldetti L; Ponticelli F; Ruparelia N; Mitomo S; Latib A; Montorfano M; Jabbour RJ; Aurelio A; Ferri L; Mangieri A; Regazzoli D; Ancona M; Pagnesi M; Faccini A; Chieffo A; Azzalini L; Carlino M; Colombo A
    JACC Cardiovasc Interv; 2018 Apr; 11(8):784-792. PubMed ID: 29673511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of the reducer: A multi-center clinical registry - REDUCE study.
    Giannini F; Baldetti L; Konigstein M; Rosseel L; Ruparelia N; Gallone G; Colombo A; Banai S; Verheye S
    Int J Cardiol; 2018 Oct; 269():40-44. PubMed ID: 29983248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study).
    Verheye S; Agostoni P; Giannini F; Hill JM; Jensen C; Lindsay S; Stella PR; Redwood S; Banai S; Konigstein M
    EuroIntervention; 2021 Sep; 17(7):561-568. PubMed ID: 33319762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary sinus narrowing therapy: A "Reducer" for angina and beyond.
    Dimitriadis K; Iliakis P; Pyrpyris N; Beneki E; Tsioufis P; Aznaouridis K; Aggeli K; Tsioufis K
    Cardiovasc Revasc Med; 2023 Dec; 57():96-105. PubMed ID: 37573172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary sinus Reducer device for the treatment of refractory angina: A multicenter initial experience.
    Ferreira Reis J; Brízido C; Madeira S; Ramos R; Almeida M; Cacela D
    Rev Port Cardiol; 2023 May; 42(5):413-420. PubMed ID: 36828185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary Sinus Reducer implantation improves symptoms, ischaemia and physical capacity in patients with refractory angina unsuitable for myocardial revascularisation: a single-centre experience.
    Konigstein M; Bazan S; Revivo M; Banai S
    EuroIntervention; 2018 Jul; 14(4):e452-e458. PubMed ID: 29688178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of coronary sinus reducer in patients with refractory angina-A systematic review of the literature.
    Bazoukis G; Brilakis ES; Tse G; Letsas KP; Kitsoulis P; Liu T; Baranchuk A; Sideris A; Tsioufis C; Stavrakis S
    J Interv Cardiol; 2018 Dec; 31(6):775-779. PubMed ID: 30191622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Coronary Sinus Reducer for Treatment of Refractory Angina: A Meta-analysis.
    Hochstadt A; Itach T; Merdler I; Ghantous E; Ziv-Baran T; Leshno M; Banai S; Konigstein M
    Can J Cardiol; 2022 Mar; 38(3):376-383. PubMed ID: 34968714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter treatment for refractory angina with the Coronary Sinus Reducer.
    Konigstein M; Meyten N; Verheye S; Schwartz M; Banai S
    EuroIntervention; 2014 Feb; 9(10):1158-64. PubMed ID: 24561732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary Sinus Narrowing Improves Coronary Microcirculation Function in Patients With Refractory Angina: A Multicenter Prospective INROAD Study.
    Tebaldi M; Campo G; Ugo F; Guarracini S; Marrone A; Clò S; Abdirashid M; Di Mauro M; Rametta F; Di Marco M; Cocco M; Marchini F; Penzo C; Erriquez A; Banai S; Biscaglia S
    Circ Cardiovasc Interv; 2024 Jan; 17(1):e013481. PubMed ID: 38227697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trial.
    Foley MJ; Rajkumar CA; Ahmed-Jushuf F; Simader F; Pathimagaraj RH; Nijjer S; Sen S; Petraco R; Clesham G; Johnson T; Harrell FE; Kellman P; Francis D; Shun-Shin M; Howard J; Cole GD; Al-Lamee R
    EuroIntervention; 2024 Feb; 20(3):e216-e223. PubMed ID: 38214677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial.
    Foley MJ; Rajkumar CA; Ahmed-Jushuf F; Simader FA; Chotai S; Pathimagaraj RH; Mohsin M; Salih A; Wang D; Dixit P; Davies JR; Keeble TR; Cosgrove C; Spratt JC; O'Kane PD; De Silva R; Hill JM; Nijjer SS; Sen S; Petraco R; Mikhail GW; Khamis R; Kotecha T; Harrell FE; Kellman P; Francis DP; Howard JP; Cole GD; Shun-Shin MJ; Al-Lamee RK
    Lancet; 2024 Apr; 403(10436):1543-1553. PubMed ID: 38604209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of Coronary Sinus Reducer implantation at 2-year follow-up.
    Ponticelli F; Tzanis G; Gallone G; Baldetti L; Mangieri A; Colombo A; Giannini F
    Int J Cardiol; 2019 Oct; 292():87-90. PubMed ID: 31176523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients.
    Gallone G; Armeni P; Verheye S; Agostoni P; Timmers L; Campo G; Ielasi A; Sgura F; Tarantini G; Rosseel L; Zivelonghi C; Leenders G; Stella P; Tebaldi M; Tespili M; D'Amico G; Baldetti L; Ponticelli F; Colombo A; Giannini F
    Eur Heart J Qual Care Clin Outcomes; 2020 Jan; 6(1):32-40. PubMed ID: 31124556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of patients undergoing coronary sinus reducer implantation - A multicenter study.
    Konigstein M; Ponticelli F; Zivelonghi C; Merdler I; Revivo M; Verheye S; Giannini F; Banai S
    Clin Cardiol; 2021 Mar; 44(3):424-428. PubMed ID: 33605473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study.
    Banai S; Ben Muvhar S; Parikh KH; Medina A; Sievert H; Seth A; Tsehori J; Paz Y; Sheinfeld A; Keren G
    J Am Coll Cardiol; 2007 May; 49(17):1783-9. PubMed ID: 17466229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience.
    Abawi M; Nijhoff F; Stella PR; Voskuil M; Benedetto D; Doevendans PA; Agostoni P
    Neth Heart J; 2016 Sep; 24(9):544-51. PubMed ID: 27299456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.